A medical bag comprising: a bag main body comprising a flexible sheet material having an interior portion partitioned via a partition part into a first space and a second space that is smaller than the first space, a first liquid housed in the first space, and a second liquid housed in the second space. When the volume of the first liquid is set as L1 and the volume of the second liquid is set as L2, L1/L2 is 2.0 to 6.0. The partition part has a breaking strength of 5 to 25 kPa.

The invention relates to a method and to a device for filling a medical packaging formed as a pouch. Preferably, the packaging is filled with liquid via a port, wherein the port is aerated with a protective gas, such as nitrogen, for example, during filling According to the invention, prior to filling with liquid, the packaging is filled with an inert gas, such as nitrogen, for example, which then provides the headspace of the filled and closed pouch. This results in a particularly low oxygen content in the headspace of the pouch.

Disclosed is a fluid bag including a main body having a fluid storage space capable of containing a fluid, an air storage space capable of containing air, and a pressing bag capable of inflating to press the main body when the air storage space is filled with the air, wherein the pressing bag is integrally connected to the main body, and wherein the air storage space includes one or more unit spaces connected to each other and spatially divided by boundary lines. According to the present invention, the main body may be pressed within a short time without excessively inflating the pressing bag, and a user may not feel anxious that the pressing bag would excessively inflate and burst.

A drug delivery system includes a delivery container, a first drug insertion port, at least one additional drug insertion port, and an IV connection port. The delivery container includes upper, lower, first side, and second side portions, and further includes a tapered region extending between the first side portion and the second side portion. The first drug insertion port is positioned at the lower portion of the delivery container and has a first coupling mechanism. The at least one additional drug insertion port is also positioned at the lower portion of the delivery container, but includes a second coupling mechanism that is different than the first coupling mechanism. The IV connection port is positioned at the lower portion of the delivery container adjacent to a lower portion of the tapered region.

A take-home drug delivery system includes a kit container defining an inner volume, a drug delivery container preparation assembly at least partially disposed within the inner volume of the kit container, and a sterile drape at least partially disposed within the inner volume of the kit container. The drug delivery container preparation assembly includes at least a drug delivery container, a drug vial containing a drug to be administered, a tubing set, and a drug delivery container mounting apparatus. The sterile drape includes a placement legend illustrated thereon.

Systems and devices for providing readily accessible and unassisted oral hydration to a patient or other individual. A hydration system of the present disclosure may include a container for holding a quantity of liquid, a hydration tube extending from the container, and a hydration control valve through which a user may access the liquid by pushing or pressing on a lever. The hydration control valve may be, or be similar to, a pinch valve or bite valve arranged across a tube, such that by opening the valve, water may be permitted to flow through the tube. The valve may be arranged within a valve casing having a hydration tube coupling portion and a mouthpiece.

A collapsible fluid reservoir may include a flexible container, a flexible filter, a first inflow line, a second inflow line, and an outflow line. The container may include a first sheet and a second sheet defining an internal space therebetween for containing a biological fluid. The filter may be disposed within the internal space and attached to the container along an entire periphery of the filter. The filter may include a first side facing the first sheet and a second side facing the second sheet. The first inflow line and the second inflow line each may be disposed at least partially within the interior space and between the first side of the filter and the first sheet. The outflow line may be disposed at least partially within the interior space and between the second side of the filter and the second sheet.

A sterile product bag includes a bladder, a stem, a filter, and a vial adaptor. The bladder has a perimeter seal and defining a sterile chamber. The stem extends through the perimeter seal and has an inlet end outside of the perimeter seal and an outlet end in fluid communication with the chamber. The filter is disposed in line with the stem and has a filter membrane with a nominal pore size in a range of approximately 0.1 m to approximately 0.5 m. The filter membrane is shaped as a hollow fiber with a wall and pores residing in the wall of the fiber. The vial adaptor includes a sterile hollow cannula, a sheath, and a peelable closure. The cannula is in fluid communication with the chamber of the bladder. The sheath is disposed outside of the bladder and connected to the hollow cannula. The sheath includes an interior cavity into which the hollow cannula extends. The peelable closure extends across an opening of the sheath to seal the interior cavity.

The disclosure provides a cell freezing and storage bag assembly and a method for using the assembly in banking eukaryotic cells for later seed train expansion. The bag is constructed principally of fluorinated ethylene propylene (FEP) fabric, and is designed to be filled such that the cell suspension has a very thin cross-section. The bag design includes at least an inlet conduit and an outlet or inoculation conduit, which can be sterilely welded to the source of the eukaryotic cells. The use of at least two sterile-weldable conduits allows for closed system filling of the bags, which significantly reduces the risk of contamination relative to other cell-banking methods. The bag also include a sleeve, which can be thermo-welded to form an enclosure, which protects the inlet and outlet conduits against contamination and mechanical damage during freezing, storage and subsequent thawing. In the method, once each bag is filled, its corresponding inlet conduit is sealed, and both the inlet and outlet conduits are enclosed within the bag's sleeve. This closed system method obviates the need for sterile environments (e.g. laminar flow unit).

The present invention provides an integrated infusion system having a drug vial container adapted to hold a drug vial, the drug vial container having a drug vial holder element and a holder cap element, wherein the drug vial holder element and the holder cap element are fused together forming a seal; and a chemical indicator inside the drug vial container for sterility verification.